A novel therapeutic target in various lung diseases: Airway proteases and protease-activated receptors
- 1 July 2007
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 115 (1) , 70-83
- https://doi.org/10.1016/j.pharmthera.2007.04.002
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Role for protease activity in visceral pain in irritable bowel syndromeJournal of Clinical Investigation, 2007
- Mesotrypsin, a brain trypsin, activates selectively proteinase‐activated receptor‐1, but not proteinase‐activated receptor‐2, in rat astrocytesJournal of Neurochemistry, 2006
- Activity of recombinant trypsin isoforms on human proteinase‐activated receptors (PAR): mesotrypsin cannot activate epithelial PAR‐1, ‐2, but weakly activates brain PAR‐1British Journal of Pharmacology, 2005
- Deficiency of PAR-2 Gene Increases Acute Focal Ischemic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2005
- Protease-activated Receptor 2 in Colon CancerJournal of Biological Chemistry, 2004
- Thrombin- and Factor Xa–Induced DNA Synthesis Is Mediated by Transactivation of Fibroblast Growth Factor Receptor-1 in Human Vascular Smooth Muscle CellsCirculation Research, 2004
- Thrombin Up-regulates Tissue Factor Pathway Inhibitor-2 Synthesis through a Cyclooxygenase-2-dependent, Epidermal Growth Factor Receptor-independent MechanismPublished by Elsevier ,2004
- Protease-Activated Receptor-1–Mediated DNA Synthesis in Cardiac Fibroblast Is via Epidermal Growth Factor Receptor TransactivationCirculation Research, 2002
- Protease-activated receptors in human airways: Upregulation of PAR-2 in respiratory epithelium from patients with asthmaJournal of Allergy and Clinical Immunology, 2001
- Direct Thrombin Inhibition Reduces Lung Collagen, Accumulation, and Connective Tissue Growth Factor mRNA Levels in Bleomycin-Induced Pulmonary FibrosisThe American Journal of Pathology, 2001